Intellectus Partners, LLC Baxter International Inc Transaction History

Intellectus Partners, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$37.58 - $52.57 $130,177 - $182,102	3,464 Added 24.91%	17,372 $704,000
Q4 2022 Feb 02, 2023	BUY	$49.7 - $57.71 $245,468 - $285,029	4,939 Added 55.07%	13,908 $708,000
Q3 2022 Nov 14, 2022	BUY	$53.86 - $66.8 $108,527 - $134,602	2,015 Added 28.98%	8,969 $485,000
Q2 2022 Aug 12, 2022	BUY	$63.83 - $80.0 $22,723 - $28,480	356 Added 5.4%	6,954 $449,000
Q1 2022 May 16, 2022	BUY	$76.85 - $89.45 $12,987 - $15,117	169 Added 2.63%	6,598 $513,000
Q4 2021 Feb 14, 2022	BUY	$74.57 - $87.19 $16,107 - $18,833	216 Added 3.48%	6,429 $551,000
Q3 2021 Nov 16, 2021	BUY	$73.77 - $83.61 $62,852 - $71,235	852 Added 15.89%	6,213 $501,000
Q2 2021 Aug 13, 2021	SELL	$80.5 - $88.01 $197,949 - $216,416	-2,459 Reduced 31.45%	5,361 $433,000
Q1 2021 May 17, 2021	BUY	$76.38 - $86.03 $597,291 - $672,754	7,820 New	7,820 $661,000
Q2 2019 Aug 08, 2019	SELL	$73.44 - $82.41 $7,490 - $8,405	-102 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$61.45 - $77.8 $18,373 - $23,262	-299 Reduced 74.56%	102 $7,000
Q2 2017 Aug 15, 2017	BUY	N/A	401	401 $24,000

1,008

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Intellectus Partners, LLC with notifications on news.